176
|
Peterson D. Interview with ACHE's incoming chairman. HEALTHCARE EXECUTIVE 2001; 16:6-11. [PMID: 11234160] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
|
177
|
Ammar R, Bean A, Besson D, Davis R, Kwak N, Zhao X, Anderson S, Frolov VV, Kubota Y, Lee SJ, Mahapatra R, O'Neill JJ, Poling R, Riehle T, Smith A, Stepaniak CJ, Urheim J, Ahmed S, Alam MS, Athar SB, Jian L, Ling L, Saleem M, Timm S, Wappler F, Anastassov A, Duboscq JE, Eckhart E, Gan KK, Gwon C, Hart T, Honscheid K, Hufnagel D, Kagan H, Kass R, Pedlar TK, Schwarthoff H, Thayer JB, von Toerne E, Zoeller MM, Richichi SJ, Severini H, Skubic P, Undrus A, Chen S, Fast J, Hinson JW, Lee J, Miller DH, Shibata EI, Shipsey IP, Pavlunin V, Cronin-Hennessy D, Lyon AL, Thorndike EH, Jessop CP, Marsiske H, Perl ML, Savinov V, Zhou X, Coan TE, Fadeyev V, Maravin Y, Narsky I, Stroynowski R, Ye J, Wlodek T, Artuso M, Ayad R, Boulahouache C, Bukin K, Dambasuren E, Karamov S, Majumder G, Moneti GC, Mountain R, Schuh S, Skwarnicki T, Stone S, Viehhauser G, Wang JC, Wolf A, Wu J, Kopp S, Mahmood AH, Csorna SE, Danko I, McLean KW, Márka S, Xu Z, Godang R, Kinoshita K, Lai IC, Schrenk S, Bonvicini G, Cinabro D, McGee S, Perera LP, Zhou GJ, Lipeles E, Pappas SP, Schmidtler M, Shapiro A, Sun WM, Weinstein AJ, Würthwein F, Jaffe DE, Masek G, Paar HP, Potter EM, Prell S, Sharma V, Asner DM, Eppich A, Hill TS, Morrison RJ, Briere RA, Chen GP, Behrens BH, Ford WT, Gritsan A, Roy J, Smith JG, Alexander JP, Baker R, Bebek C, Berger BE, Berkelman K, Blanc F, Boisvert V, Cassel DG, Dickson M, Drell PS, Ecklund KM, Ehrlich R, Foland AD, Gaidarev P, Galik RS, Gibbons L, Gittelman B, Gray SW, Hartill DL, Heltsley BK, Hopman PI, Jones CD, Kreinick DL, Lohner M, Magerkurth A, Meyer TO, Mistry NB, Nordberg E, Patterson JR, Peterson D, Riley D, Thayer JG, Urner D, Valant-Spaight B, Warburton A, Avery P, Prescott C, Rubiera AI, Yelton J, Zheng J, Brandenburg G, Ershov A, Gao YS, Kim DY, Wilson R, Browder TE, Li Y, Rodriguez JL, Yamamoto H, Bergfeld T, Eisenstein BI, Ernst J, Gladding GE, Gollin GD, Hans RM, Johnson E, Karliner I, Marsh MA, Palmer M, Plager C, Sedlack C, Selen M, Thaler JJ, Williams J, Edwards KW, Janicek R, Patel PM, Sadoff AJ. First observation of the sigma(*+)(c) baryon and a new measurement of the sigma(*+)(c) mass. PHYSICAL REVIEW LETTERS 2001; 86:1167-1170. [PMID: 11178035 DOI: 10.1103/physrevlett.86.1167] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/19/2000] [Indexed: 05/23/2023]
Abstract
Using data recorded with the CLEO II and CLEO II.V detector configurations at the Cornell Electron Storage Rings, we report the first observation and mass measurement of the Sigma(*+)(c) charmed baryon, and an updated measurement of the mass of the Sigma(+)(c) baryon. We find M(Sigma(*+)(c))-M(Lambda(+)(c)) = (231.0+/-1.1+/-2.0) MeV, and M(Sigma(+)(c))-M(Lambda(+)(c)) = (166.4+/-0.2+/-0.3) MeV, where the errors are statistical and systematic, respectively.
Collapse
|
178
|
Edwards KW, Janicek R, Patel PM, Sadoff AJ, Ammar R, Bean A, Besson D, Davis R, Kwak N, Zhao X, Anderson S, Frolov VV, Kubota Y, Lee SJ, Mahapatra R, O'Neill JJ, Poling R, Riehle T, Smith A, Stepaniak CJ, Urheim J, Ahmed S, Alam MS, Athar SB, Jian L, Ling L, Saleem M, Timm S, Wappler F, Anastassov A, Duboscq JE, Eckhart E, Gan KK, Gwon C, Hart T, Honscheid K, Hufnagel D, Kagan H, Kass R, Pedlar TK, Schwarthoff H, Thayer JB, Zoeller MM, Richichi SJ, Severini H, Skubic P, Undrus A, Chen S, Fast J, Hinson JW, Lee J, Miller DH, Shibata EI, Shipsey IP, Pavlunin V, Cronin-Hennessy D, Lyon AL, Thorndike EH, Jessop CP, Marsiske H, Perl ML, Savinov V, Ugolini D, Zhou X, Coan TE, Fadeyev V, Maravin Y, Narsky I, Stroynowski R, Ye J, Wlodek T, Artuso M, Ayad R, Boulahouache C, Bukin K, Dambasuren E, Karamov S, Majumder G, Moneti GC, Mountain R, Schuh S, Skwarnicki T, Stone S, Viehhauser G, Wang JC, Wolf A, Wu J, Kopp S, Mahmood AH, Csorna SE, Danko I, McLean KW, Márka S, Xu Z, Godang R, Kinoshita K, Lai IC, Schrenk S, Bonvicini G, Cinabro D, McGee S, Perera LP, Zhou GJ, Lipeles E, Pappas SP, Schmidtler M, Shapiro A, Sun WM, Weinstein AJ, Würthwein F, Jaffe DE, Masek G, Paar HP, Potter EM, Prell S, Sharma V, Asner DM, Eppich A, Hill TS, Morrison RJ, Briere RA, Behrens BH, Ford WT, Gritsan A, Roy J, Smith JG, Alexander JP, Baker R, Bebek C, Berger BE, Berkelman K, Blanc F, Boisvert V, Cassel DG, Dickson M, Drell PS, Ecklund KM, Ehrlich R, Foland AD, Gaidarev P, Gibbons L, Gittelman B, Gray SW, Hartill DL, Heltsley BK, Hopman PI, Jones CD, Kreinick DL, Lohner M, Magerkurth A, Meyer TO, Mistry NB, Nordberg E, Patterson JR, Peterson D, Riley D, Thayer JG, Thies PG, Valant-Spaight B, Warburton A, Avery P, Prescott C, Rubiera AI, Yelton J, Zheng J, Brandenburg G, Ershov A, Gao YS, Kim DY, Wilson R, Browder TE, Li Y, Rodriguez JL, Yamamoto H, Bergfeld T, Eisenstein BI, Ernst J, Gladding GE, Gollin GD, Hans RM, Johnson E, Karliner I, Marsh MA, Palmer M, Plager C, Sedlack C, Selen M, Thaler JJ, Williams J. Study of B Decays to Charmonium States: B-->eta(c)K and B --> chi(c0)K. PHYSICAL REVIEW LETTERS 2001; 86:30-34. [PMID: 11136086 DOI: 10.1103/physrevlett.86.30] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/07/2000] [Indexed: 05/23/2023]
Abstract
In a sample of 9.66x10(6)B&Bmacr; pairs collected with the CLEO detector we make the first observation of B decays to an eta(c) and a kaon. We measure branching fractions B(B+-->eta(c)K+) = (0.69(+0.26)(-0.21)+/-0.08+/-0.20)x10(-3) and B(B degrees -->eta(c)K degrees ) = (1.09(+0.55)(-0.42)+/-0.12+/-0.31)x10(-3), where the first error is statistical, the second is systematic, and the third is from the eta(c) branching fraction uncertainty. From these we extract the eta(c) decay constant in the factorization approximation, f(eta(c)) = 335+/-75 MeV. We also search for B decays to a chi(c0) and a kaon. No evidence for a signal is found and we set 90% C.L. upper limits: B(B+-->chi(c0)K+)<4.8x10(-4) and B(B degrees -->chi(c0)K degrees )<5.0x10(-4).
Collapse
|
179
|
Wilson C, Susan L, Lynch A, Saria R, Peterson D. Patients with diagnosed diabetes mellitus can be accurately identified in an Indian Health Service patient registration database. Public Health Rep 2001; 116:45-50. [PMID: 11571407 PMCID: PMC1497292 DOI: 10.1093/phr/116.1.45] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
OBJECTIVE The computerized patient registration databases maintained by the Indian Health Service (IHS) represent a potentially important source of data about the epidemic of diabetes among American Indian and Alaskan Native people. The purpose of this study is to determine the accuracy of this data source, and to identify the optimal search criteria to identify patients with a diagnosis of diabetes in an IHS patient registration database. METHODS The authors compared the results of a series of computerized searches to a "gold standard" sample of 465 manually reviewed charts from a large IHS facility. RESULTS Among patients ages 15 years and older, the best criterion for identifying patients diagnosed with diabetes was the presence of at least one purpose of visit narrative identified by a 250.00 to 250.93 ICD-9 code. The presence of a single computerized code for diabetes identified patients with diagnosed diabetes with a sensitivity of 92% (95% confidence interval [CI] 81, 97), a specificity of 99% (95% CI 98, 99), and a calculated positive predictive value of 94% (95% CI 85, 99). In a separate chart review of 462 charts of patients who had at least one 250.00 to 250.93 ICD-9 code recorded in the database, 435 had a diagnosis of diabetes for an observed positive predictive value of 94%. Because the prevalence of diabetes varies by age of the patient, the positive predictive value of the ability to identify patients with diabetes also varies by age. CONCLUSION A computerized search of an IHS patient database can identify patients with a diagnosis of diabetes with an accuracy that is similar to the reported accuracy from other health care system databases.
Collapse
|
180
|
Brandenburg G, Ershov A, Gao YS, Kim DY, Wilson R, Browder TE, Li Y, Rodriguez JL, Yamamoto H, Bergfeld T, Eisenstein BI, Ernst J, Gladding GE, Gollin GD, Hans RM, Johnson E, Karliner I, Marsh MA, Palmer M, Plager C, Sedlack C, Selen M, Thaler JJ, Williams J, Edwards KW, Janicek R, Patel PM, Sadoff AJ, Ammar R, Bean A, Besson D, Davis R, Kwak N, Zhao X, Anderson S, Frolov VV, Kubota Y, Lee SJ, Mahapatra R, O'Neill JJ, Poling R, Riehle T, Smith A, Stepaniak CJ, Urheim J, Ahmed S, Alam MS, Athar SB, Jian L, Ling L, Saleem M, Timm S, Wappler F, Anastassov A, Duboscq JE, Eckhart E, Gan KK, Gwon C, Hart T, Honscheid K, Hufnagel D, Kagan H, Kass R, Pedlar TK, Schwarthoff H, Thayer JB, von Toerne E, Zoeller MM, Richichi SJ, Severini H, Skubic P, Undrus A, Chen S, Fast J, Hinson JW, Lee J, Miller DH, Shibata EI, Shipsey IP, Pavlunin V, Cronin-Hennessy D, Lyon AL, Thorndike EH, Jessop CP, Marsiske H, Perl ML, Savinov V, Ugolini D, Zhou X, Coan TE, Fadeyev V, Maravin Y, Narsky I, Stroynowski R, Ye J, Wlodek T, Artuso M, Ayad R, Boulahouache C, Bukin K, Dambasuren E, Karamov S, Majumder G, Moneti GC, Mountain R, Schuh S, Skwarnicki T, Stone S, Viehhauser G, Wang JC, Wolf A, Wu J, Kopp S, Mahmood AH, Csorna SE, Danko I, McLean KW, Márka S, Xu Z, Godang R, Kinoshita K, Lai IC, Schrenk S, Bonvicini G, Cinabro D, McGee S, Perera LP, Zhou GJ, Lipeles E, Pappas SP, Schmidtler M, Shapiro A, Sun WM, Weinstein AJ, Würthwein F, Jaffe DE, Masek G, Paar HP, Potter EM, Prell S, Sharma V, Asner DM, Eppich A, Hill TS, Morrison RJ, Briere RA, Ferguson T, Vogel H, Behrens BH, Ford WT, Gritsan A, Roy J, Smith JG, Alexander JP, Baker R, Bebek C, Berger BE, Berkelman K, Blanc F, Boisvert V, Cassel DG, Dickson M, Drell PS, Ecklund KM, Ehrlich R, Foland AD, Gaidarev P, Galik RS, Gibbons L, Gittelman B, Gray SW, Hartill DL, Heltsley BK, Hopman PI, Jones CD, Kreinick DL, Lohner M, Magerkurth A, Meyer TO, Mistry NB, Nordberg E, Patterson JR, Peterson D, Riley D, Thayer JG, Thies PG, Urner D, Valant-Spaight B, Warburton A, Avery P, Prescott C, Rubiera AI, Yelton J, Zheng J. Measurements of the mass, total width, and two-photon partial width of the eta(c) meson. PHYSICAL REVIEW LETTERS 2000; 85:3095-3099. [PMID: 11019275 DOI: 10.1103/physrevlett.85.3095] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/20/2000] [Indexed: 05/23/2023]
Abstract
Using 13.4 fb(-1) of data collected with the CLEO detector at the Cornell Electron Storage Ring, we have observed 300 events for the two-photon production of ground-state pseudoscalar charmonium in the decay eta(c)-->K(0)(S)K-/+pi(+/-). We have measured the eta(c) mass to be [2980.4+/-2.3 (stat)+/-0.6 (syst)] MeV and its full width as [27.0+/-5.8 (stat)+/-1.4 (syst)] MeV. We have determined the two-photon partial width of the eta(c) meson to be [7.6+/-0.8 (stat)+/-0.4 (syst)+/-2.3 (br)] keV, with the last uncertainty associated with the decay branching fraction.
Collapse
|
181
|
Jessop CP, Marsiske H, Perl ML, Savinov V, Ugolini D, Zhou X, Coan TE, Fadeyev V, Maravin Y, Narsky I, Stroynowski R, Ye J, Wlodek T, Artuso M, Ayad R, Boulahouache C, Bukin K, Dambasuren E, Karamov S, Majumder G, Moneti GC, Mountain R, Schuh S, Skwarnicki T, Stone S, Viehhauser G, Wang JC, Wolf A, Wu J, Kopp S, Csorna SE, Danko I, McLean KW, Márka S, Xu Z, Godang R, Kinoshita K, Lai IC, Schrenk S, Bonvicini G, Cinabro D, McGee S, Perera LP, Zhou GJ, Lipeles E, Schmidtler M, Shapiro A, Sun WM, Weinstein AJ, Würthwein F, Jaffe DE, Masek G, Paar HP, Potter EM, Prell S, Sharma V, Asner DM, Eppich A, Hill TS, Morrison RJ, Nelson HN, Briere RA, Behrens BH, Ford WT, Gritsan A, Roy J, Smith JG, Alexander JP, Baker R, Bebek C, Berger BE, Berkelman K, Blanc F, Boisvert V, Cassel DG, Dickson M, Drell PS, Ecklund KM, Ehrlich R, Foland AD, Gaidarev P, Gibbons L, Gittelman B, Gray SW, Hartill DL, Heltsley BK, Hopman PI, Jones CD, Kreinick DL, Lohner M, Magerkurth A, Meyer TO, Mistry NB, Nordberg E, Patterson JR, Peterson D, Riley D, Thayer JG, Thies PG, Valant-Spaight B, Warburton A, Avery P, Prescott C, Rubiera AI, Yelton J, Zheng J, Brandenburg G, Ershov A, Gao YS, Kim DY, Wilson R, Browder TE, Li Y, Rodriguez JL, Yamamoto H, Bergfeld T, Eisenstein BI, Ernst J, Gladding GE, Gollin GD, Hans RM, Johnson E, Karliner I, Marsh MA, Palmer M, Plager C, Sedlack C, Selen M, Thaler JJ, Williams J, Edwards KW, Janicek R, Patel PM, Sadoff AJ, Ammar R, Bean A, Besson D, Davis R, Kwak N, Zhao X, Anderson S, Frolov VV, Kubota Y, Lee SJ, Mahapatra R, O'Neill JJ, Poling R, Riehle T, Smith A, Urheim J, Ahmed S, Alam MS, Athar SB, Jian L, Ling L, Mahmood AH, Saleem M, Timm S, Wappler F, Anastassov A, Duboscq JE, Gan KK, Gwon C, Hart T, Honscheid K, Hufnagel D, Kagan H, Kass R, Pedlar TK, Schwarthoff H, Thayer JB, von Toerne E, Zoeller MM, Richichi J, Severini H, Skubic P, Undrus A, Chen S, Fast J, Hinson JW, Lee J, Menon N, Miller DH, Shibata EI, Shipsey IP, Pavlunin V, Cronin-Hennessy D, Kwon Y, Lyon AL, Thorndike EH. Study of charmless hadronic B meson decays to pseudoscalar-vector final states. PHYSICAL REVIEW LETTERS 2000; 85:2881-2885. [PMID: 11005959 DOI: 10.1103/physrevlett.85.2881] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/30/2000] [Indexed: 05/23/2023]
Abstract
We report results of searches for charmless hadronic B meson decays to pseudoscalar( pi(+/-), K+/-, pi(0), or K(0)(S))-vector( rho, K(*), or omega) final states. By using 9.7x10(6) BB pairs collected with the CLEO detector, we report the first observation of B(-)--->pi(-)rho(0), B(0)-->pi(+/-)rho(-/+), and B(-)-->pi(-)omega, which are expected to be dominated by hadronic b-->u transitions. The measured branching fractions are (10.4(+3.3)(-3.4)+/-2.1)x10(-6), (27.6(+8.4)(-7.4)+/-4.2)x10(-6), and (11.3(+3.3)(-2.9)+/-1. 4)x10(-6), respectively. Branching fraction upper limits are set for all of the other decay modes investigated.
Collapse
|
182
|
Yang Q, Tian Y, Wada J, Kashihara N, Wallner E, Peterson D, Kanwar YS. Expression characteristics and relevance of sodium glucose cotransporter-1 in mammalian renal tubulogenesis. Am J Physiol Renal Physiol 2000; 279:F765-77. [PMID: 10997927 DOI: 10.1152/ajprenal.2000.279.4.f765] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Expression and role of sodium glucose cotransporter (SGLT-1) in tubulogenesis were investigated during renal development. A mouse SGLT-1 cDNA was cloned, and it had substantial homology with human and rat forms. Four mRNA transcripts were detected, which differed in size from other species. SGLT-1 transcripts were detected at day 13 of gestation, and their expression increased during later stages extending into the postnatal period. A high mRNA and protein expression of SGLT-1 was seen in tubular segments of the inner cortex and outer medulla at day 16, and it was developmentally regulated. Treatment with SGLT-1 antisense selectively decreased the population of tubules in the metanephric explants. Expression of glomerular mRNA and WGA binding were unchanged. SGLT-1 activity, as measured by [(14)C]methyl-alpha-D-glucopyranoside uptake, increased during gestation in the tubular segments where it is expressed. Glucose uptake was inhibited by the treatment with SGLT-1 antisense and D-galactose. The data suggest that SGLT-1 exhibits a restricted spatiotemporal expression with functional activity confined to the corresponding tubular segments, and it selectively maintains renal tubulogenesis during development.
Collapse
|
183
|
Wijsman EM, Peterson D, Leutenegger AL, Thomson JB, Goddard KA, Hsu L, Berninger VW, Raskind WH. Segregation analysis of phenotypic components of learning disabilities. I. Nonword memory and digit span. Am J Hum Genet 2000; 67:631-46. [PMID: 10924405 PMCID: PMC1287523 DOI: 10.1086/303044] [Citation(s) in RCA: 64] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/03/2000] [Accepted: 07/06/2000] [Indexed: 11/04/2022] Open
Abstract
Dyslexia is a common and complex disorder with evidence for a genetic component. Multiple loci (i.e., quantitative-trait loci [QTLs]) are likely to be involved, but the number is unknown. Diagnosis is complicated by the lack of a standard protocol, and many diagnostic measures have been proposed as understanding of the component processes has evolved. One or more genes may, in turn, influence these measures. To date, little work has been done to evaluate the mode of inheritance of individual component-as opposed to composite-phenotypes, beyond family or twin correlation studies that initially demonstrate evidence for a genetic basis of such components. Here we use two approaches to segregation analysis in 102 nuclear families to estimate genetic models for component phenotypes associated with dyslexia: digit span and a nonword-repetition task. Both measures are related to phonological skills, one of the key component processes in dyslexia. We use oligogenic-trait segregation analysis to estimate the number of QTLs contributing to each phenotype, and we use complex segregation analysis to identify the most parsimonious inheritance models. We provide evidence in support of both a major-gene mode of inheritance for the nonword-repetition task, with approximately 2.4 contributing QTLs, and for a genetic basis of digit span, with approximately 1.9 contributing QTLs. Results obtained by reciprocal adjustment of measures suggest that genes contributing to digit span may contribute to the nonword-repetition score but that there are additional QTLs involved in nonword repetition. Our study adds to existing studies of the genetic basis of composite phenotypes related to dyslexia, by providing evidence for major-gene modes of inheritance of these single-measure component phenotypes.
Collapse
|
184
|
|
185
|
Eron JJ, Murphy RL, Peterson D, Pottage J, Parenti DM, Jemsek J, Swindells S, Sepulveda G, Bellos N, Rashbaum BC, Esinhart J, Schoellkopf N, Grosso R, Stevens M. A comparison of stavudine, didanosine and indinavir with zidovudine, lamivudine and indinavir for the initial treatment of HIV-1 infected individuals: selection of thymidine analog regimen therapy (START II). AIDS 2000; 14:1601-10. [PMID: 10983647 DOI: 10.1097/00002030-200007280-00016] [Citation(s) in RCA: 68] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OBJECTIVE Comparison of stavudine (d4T), didanosine (ddI) and indinavir (IDV) with zidovudine (ZDV), lamivudine (3TC) and IDV in HIV-1 infected patients. DESIGN Randomized, open-label. SETTING Fourteen HIV Clinical Research Centers. PATIENTS Two-hundred and five patients with less than 4 weeks antiretroviral treatment, naive to 3TC and protease inhibitors and with CD4 cell counts > or = 200 x 10(6)/l and plasma HIV-1 RNA levels > or = 10,000 copies/ml. INTERVENTIONS Stavudine 40 mg and ddI 200 mg twice daily plus IDV 800 mg every 8 h compared with ZDV 200 mg every 8 h or 300 mg twice daily, 3TC 150 mg twice daily plus IDV. MAIN OUTCOME MEASURES The proportion of patients with plasma HIV-1 RNA levels < 500 copies/ml and < or = 50 copies/ml and changes in CD4 cell counts were compared. RESULTS In an analysis of the primary endpoint, 61% of patients on d4T + ddI + IDV and 45% of patients on ZDV + 3TC + IDV had all HIV-1 RNA values obtained between weeks 40 and 48 < 500 copies/ml [95% confidence interval (CI) for the difference between proportions, 1.7-30.3%; P = 0.038]. In an intent-to-treat analysis, the percentage of all patients randomized with all HIV-1 RNA levels < 500 copies/ml between 40 and 48 weeks were 53% for the d4T + ddI + IDV arm and 41% for the ZDV + 3TC + IDV arm (95% CI, -1.4% to 25.7%; P = 0.068). At 48 weeks 41% and 35% were < or = 50 copies/ml for the stavudine- and ZDV-containing arms respectively (P > 0.2). The median time-weighted average increases in CD4 cells count over 48 weeks were 150 x 10(6)/l cells for the d4T arm and 106 x 10(6)/l cells for the ZDV arm (P= 0.001). The occurrence of serious adverse events was not significantly different between arms. CONCLUSION The combination of stavudine, ddl and IDV resulted in potent antiretroviral effects over a 48-week period, comparable or superior to zidovudine, 3TC and IDV supporting the use of stavudine, ddI and a protease inhibitor as an initial antiretroviral treatment.
Collapse
|
186
|
Graham MA, Eich C, Kephart B, Peterson D. Relationship among body image, sex, and popularity of high school students. Percept Mot Skills 2000; 90:1187-93. [PMID: 10939068 DOI: 10.2466/pms.2000.90.3c.1187] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Body dissatisfaction and attempts to lose weight are increasingly common among adolescents. Research has identified a number of factors significantly associated with body image, including sex, media, parental relationship, and puberty as well as weight and popularity. It was hypothesized that popular adolescents would have greater body dissatisfaction, more body distortion, and lower body esteem. From a rural high school 116 10th and 12th grade students were surveyed. Two teachers from the school also completed a Body Image Figure scale for each student. Subjects rated each grade member on a 5-point Likert-type scale, indicating how much they liked the classmate. A Social Preference rating (Popularity) was calculated for each subject from these ratings. Each subject also completed a Body Image Figure scale and Body Esteem scale. Body distortion was calculated by comparing the teachers' and a student's responses. Significant sex differences were found for scores on body satisfaction, distortion, and esteem, but none for popularity with distortion and body esteem. A relationship between popularity and body satisfaction was found, with the most popular adolescents reporting the least discrepancy between their ideal body image and their current body image. Popular adolescents are most satisfied with their body type.
Collapse
|
187
|
Callahan CW, Peterson D. Treatment of acute asthma in a field environment using albuterol and a large volume spacer. Mil Med 2000; 165:449. [PMID: 10870360] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/16/2023] Open
|
188
|
Aguilera EF, Kolata JJ, Nunes FM, Becchetti FD, DeYoung PA, Goupell M, Guimaraes V, Hughey B, Lee MY, Lizcano D, Martinez-Quiroz E, Nowlin A, O'Donnell TW, Peaslee GF, Peterson D, Santi P, White-Stevens R. Transfer and/or breakup modes in the 6He+209Bi reaction near the coulomb barrier. PHYSICAL REVIEW LETTERS 2000; 84:5058-5061. [PMID: 10990866 DOI: 10.1103/physrevlett.84.5058] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/19/1999] [Indexed: 05/23/2023]
Abstract
Reaction products from the interaction of 6He with 209Bi have been measured at energies near the Coulomb barrier. A 4He group of remarkable intensity, which dominates the total reaction cross section, has been observed. The angular distribution of the group suggests that it results primarily from a direct nuclear process. It is likely that this transfer and/or breakup channel is the doorway state that accounts for the previously observed large sub-barrier fusion enhancement in this system.
Collapse
|
189
|
Kelly MB, Waterhouse N, Slade DE, Carr R, Peterson D. A 5-year review of 71 consecutive anterior skull base tumours. BRITISH JOURNAL OF PLASTIC SURGERY 2000; 53:184-90. [PMID: 10738321 DOI: 10.1054/bjps.1999.3297] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Techniques used in craniofacial surgery have found extensive application in the management of skull base tumours. The improved exposure gained via osteotomies for facial disassembly has facilitated the en-bloc resection of tumours with clear surgical margins, and the advent of vascularised seals has significantly reduced the risk of meningeal contamination. We present our experience with the extirpation and reconstruction of 71 benign and malignant tumours of the anterior skull base over a 5-year period. Survival and functional outcome data are presented, with an emphasis on the wide range of pathologies and primary treatment strategies seen at presentation. Criteria used in flap selection and the role of prosthetics are discussed. Observations are offered on salvage surgery, demonstrating that excellent palliation can be achieved, even in cases with massive recurrent disease.
Collapse
|
190
|
Guimaraes V, Kolata JJ, Peterson D, Santi P, White-Stevens RH, Vincent SM, Becchetti FD, Lee MY, O'Donnell TW, Roberts DA, Zimmerman JA. Nuclear and coulomb interaction in 8B breakup at sub-coulomb energies. PHYSICAL REVIEW LETTERS 2000; 84:1862-1865. [PMID: 11017646 DOI: 10.1103/physrevlett.84.1862] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/24/1999] [Indexed: 05/23/2023]
Abstract
The angular distribution for the breakup of 8B-->7Be+p on a 58Ni target has been measured at an incident energy of 25.75 MeV. The data are inconsistent with first-order theories but are remarkably well described by calculations including higher-order effects. The comparison with theory illustrates the importance of the inclusion of the exotic proton halo structure of 8B in accounting for the data.
Collapse
|
191
|
Balesaria S, Brock C, Bower M, Clark J, Nicholson SK, Lewis P, de Sanctis S, Evans H, Peterson D, Mendoza N, Glaser MG, Newlands ES, Fisher RA. Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas. Br J Cancer 1999; 81:1371-7. [PMID: 10604735 PMCID: PMC2362970 DOI: 10.1038/sj.bjc.6693403] [Citation(s) in RCA: 42] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/03/2022] Open
Abstract
Loss of heterozygosity (LOH) for chromosome 10 is the most frequent genetic abnormality observed in high-grade gliomas. We have used fluorescent microsatellite markers to examine a series of 83 patients, 34 with anaplastic astrocytoma (grade 3) and 49 with glioblastoma multiforme (grade 4), for LOH of chromosome 10. Genotype analysis revealed LOH for all informative chromosome 10 markers in 12 (35%) of patients with grade 3 and 29 (59%) grade 4 tumours respectively, while partial LOH was found in a further eight (24%) grade 3 and ten (20%) grade 4 tumours. Partial LOH, was confined to the long arm (10q) in six and the short arm (10p) in three cases, while alleles from both arms were lost in four cases. Five tumours (one grade 3 and four grade 4) showed heterogeneity with respect to loss at different loci. There was a correlation between any chromosome 10 loss and poorer performance status at presentation (chi2 P = 0.005) and with increasing age at diagnosis (Mann-Whitney U-test P = 0.034) but not with tumour grade (chi2 p= 0.051). A Cox multivariate model for survival duration identified age (proportional hazards (PH), P= 0.004), grade (PH, P= 0.012) and any loss of chromosome 10 (PH, P= 0.009) as the only independent prognostic variables. Specifically, LOH for chromosome 10 was able to identify a subgroup of patients with grade 3 tumours who had a significantly shorter survival time. We conclude that LOH for chromosome 10 is an independent, adverse prognostic variable in high-grade glioma.
Collapse
|
192
|
Pollard RB, Peterson D, Hardy D, Pottage J, Murphy RL, Gathe J, Beall G, Rutkievicz V, Reynolds L, Cross AP, Dunkle LM. Safety and antiretroviral effects of combined didanosine and stavudine therapy in HIV-infected individuals with CD4 counts of 200 to 500 cells/mm3. J Acquir Immune Defic Syndr 1999; 22:39-48. [PMID: 10534145 DOI: 10.1097/00042560-199909010-00005] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
The safety and antiretroviral effects of didanosine and stavudine in combination were evaluated in 86 people infected with HIV with CD4 counts between 200 and 500 cells/mm3 who had received <7 days of prior nucleoside analogue antiretroviral treatment. Patients were randomized to receive blinded treatments with one of five weight-adjusted, twice-daily regimens of didanosine and stavudine (100 + 10 mg, 100 + 20 mg, 100 + 40 mg, 200 + 20 mg, and 200 + 40 mg) for up to 1 year. Dosages were adjusted appropriately for patients weighing <60 kg and reduced in response to adverse effects. No clear dose-related differences among treatment groups were detected with regard to suppression of plasma HIV RNA level or reduction in infectious titers in peripheral blood mononuclear cells (PBMCs), improvement in CD4 count, or adverse effects. However, trends toward greater decreases in viral load and increases in CD4 count were detected when treatment groups containing the full recommended dosage of one or both agents (high-dose subgroup; arms 3, 4, and 5) were compared with the groups receiving lower dosages. At 28 weeks the mean log 10 HIV RNA decrease was 1.12 (n = 52) and at 52 weeks it was 0.97 (n = 32). Combination therapy was well tolerated, with no apparent dose-related adverse effects. Peripheral neuropathy occurred in 2 of 86 (2.3%) of patients. Didanosine and stavudine together appear to be a good nucleoside analogue foundation for aggressive triple- or quadruple-drug therapy. Full therapeutic doses of each of these two agents should be used to achieve optimal suppression of HIV replication.
Collapse
|
193
|
Patel N, Brinkman-Van der Linden EC, Altmann SW, Gish K, Balasubramanian S, Timans JC, Peterson D, Bell MP, Bazan JF, Varki A, Kastelein RA. OB-BP1/Siglec-6. a leptin- and sialic acid-binding protein of the immunoglobulin superfamily. J Biol Chem 1999; 274:22729-38. [PMID: 10428856 DOI: 10.1074/jbc.274.32.22729] [Citation(s) in RCA: 132] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023] Open
Abstract
We report the expression cloning of a novel leptin-binding protein of the immunoglobulin superfamily (OB-BP1) and a cross-hybridizing clone (OB-BP2) that is identical to a recently described sialic acid-binding I-type lectin called Siglec-5. Comparisons to other known Siglec family members (CD22, CD33, myelin-associated glycoprotein, and sialoadhesin) show that OB-BP1, OB-BP2/Siglec-5, and CD33/Siglec-3 constitute a unique related subgroup with a high level of overall amino acid identity: OB-BP1 versus Siglec-5 (59%), OB-BP1 versus CD33 (63%), and OB-BP2/Siglec-5 versus CD33 (56%). The cytoplasmic domains are not as highly conserved, but display novel motifs which are putative sites of tyrosine phosphorylation, including an immunoreceptor tyrosine kinase inhibitory motif and a motif found in SLAM and SLAM-like proteins. Human tissues showed high levels of OB-BP1 mRNA in placenta and moderate expression in spleen, peripheral blood leukocytes, and small intestine. OB-BP2/Siglec-5 mRNA was detected in peripheral blood leukocytes, lung, spleen, and placenta. A monoclonal antibody specific for OB-BP1 confirmed high expression in the cyto- and syncytiotrophoblasts of the placenta. Using this antibody on peripheral blood leukocytes showed an almost exclusive expression pattern on B cells. Recombinant forms of the extracellular domains of OB-BP1, OB-BP2/Siglec-5, and CD33/Siglec-3 were assayed for specific binding of leptin. While OB-BP1 exhibited tight binding (K(d) 91 nM), the other two showed weak binding with K(d) values in the 1-2 microM range. Studies with sialylated ligands indicated that OB-BP1 selectively bound Neu5Acalpha2-6GalNAcalpha (sialyl-Tn) allowing its formal designation as Siglec-6. The identification of OB-BP1/Siglec-6 as a Siglec family member, coupled with its restricted expression pattern, suggests that it may mediate cell-cell recognition events by interacting with sialylated glycoprotein ligands expressed on specific cell populations. We also propose a role for OB-BP1 in leptin physiology, as a molecular sink to regulate leptin serum levels.
Collapse
MESH Headings
- Amino Acid Sequence
- Antigens, CD/genetics
- Antigens, CD/isolation & purification
- Antigens, CD/metabolism
- Antigens, Differentiation, Myelomonocytic/genetics
- Antigens, Differentiation, Myelomonocytic/isolation & purification
- Antigens, Differentiation, Myelomonocytic/metabolism
- Cloning, Molecular
- DNA, Complementary/genetics
- Evolution, Molecular
- Female
- Gene Expression
- Humans
- Immunoglobulins/genetics
- Lectins
- Leptin
- Ligands
- Molecular Sequence Data
- Multigene Family
- N-Acetylneuraminic Acid/metabolism
- Placenta/chemistry
- Pregnancy
- Protein Binding
- Proteins/metabolism
- Sequence Analysis, DNA
- Sequence Homology, Amino Acid
- Sialic Acid Binding Ig-like Lectin 3
- Tissue Distribution
Collapse
|
194
|
Chen M, Sällberg M, Sönnerborg A, Weiland O, Mattsson L, Jin L, Birkett A, Peterson D, Milich DR. Limited humoral immunity in hepatitis C virus infection. Gastroenterology 1999; 116:135-43. [PMID: 9869611 DOI: 10.1016/s0016-5085(99)70237-4] [Citation(s) in RCA: 125] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
Abstract
BACKGROUND & AIMS The extremely high rate of chronicity to hepatitis C virus (HVC) infection suggests an inefficient immune response. The humoral immune response to HCV was evaluated in 60 patients with chronic HCV infection and in 12 patients acutely infected with HCV. METHODS A number of recombinant HCV antigens including the core, envelope 2 (E2), nonstructural (NS) 3, NS4, and NS5 proteins, and NS4a and E2-HVR-1 peptides were used in enzyme-linked immunoassays. RESULTS Immunoglobulin (Ig) G antibody responses to these viral antigens, except for the HCV core, were highly restricted to the IgG1 isotype. The prevalence of antibodies of the IgG1 isotype specific for the HCV core, E2, E2-HVR1, NS3 (helicase domain), NS4, and NS5 antigens was 97%, 98%, 28%, 88%, 33%, and 68%, respectively. Antibodies of the IgG3 isotype specific for E2, E2-HVR-1, NS3, NS4, and NS5 were detected in a minority of serum samples. The IgG2 and IgG4 isotypes were rarely if ever detected. Furthermore, antibody responses to HCV viral antigens were of relatively low titer and, with the exception of anti-HCV core, were delayed in appearance until the chronic phase of infection. CONCLUSIONS The IgG1 restriction, low titer, and delayed appearance of antibody responses elicited during HCV infection suggest that the immunogenicity of HCV proteins is limited in the context of natural infection. Inasmuch as recombinant HCV viral antigens perform as relatively normal immunogens in small animals, we suggest that the defective humoral immune responses during HCV infection may be attributable to an "immune avoidance" strategy.
Collapse
|
195
|
Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, Van Stone J, Levey A, Meyer KB, Klag MJ, Johnson HK, Clark E, Sadler JH, Teredesai P. "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int 1998; 54:561-9. [PMID: 9690224 DOI: 10.1046/j.1523-1755.1998.00005.x] [Citation(s) in RCA: 482] [Impact Index Per Article: 18.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
BACKGROUND Hypertension may play an important role in the pathogenesis of the excess cardiovascular and cerebrovascular (CV) morbidity observed in hemodialysis patients (HD). However, the optimal blood pressure (BP) range for HD patients has not been defined. We postulated that there is a "U" curve relationship between BP and CV mortality. To explore this hypothesis we studied 5,433 HD patients in Dialysis Clinic Inc., a large not-for-profit chain, over a five year period. METHODS Cox regression, with fixed and time-varying covariates, was used to assess the effect of systolic blood pressure (SBP) and diastolic blood pressure (DBP), pre- and post-dialysis, on CV mortality, while adjusting for age, gender, ethnicity, primary cause of end-stage renal disease, Kt/V, serum albumin, and antihypertensive medications. RESULTS The overall impact of BP on CV mortality was modest. Pre-dialysis, neither systolic nor diastolic hypertension were associated with an increase in CV mortality. Post-dialysis, SBP > or = 180 mm Hg (RR = 1.96, P < 0.015) and DBP > or = 90 mm Hg (RR = 1.73, P < 0.05) were associated with increased CV mortality. Low SBP (SBP < 110 mm Hg) was associated with increased CV mortality, pre- and post-dialysis. CONCLUSIONS The results suggest the presence of a "U" curve relationship between SBP post-dialysis and CV mortality in HD patients.
Collapse
|
196
|
Chen M, Sällberg M, Sönnerborg A, Jin L, Birkett A, Peterson D, Weiland O, Milich DR. Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein. Hepatology 1998; 28:219-24. [PMID: 9657115 DOI: 10.1002/hep.510280128] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/07/2022]
Abstract
The hepatitis C virus (HCV) nonstructural (NS) 3 protein has been shown to possess at least two enzymatic domains. The amino terminal third contains a serine-protease domain, whereas the carboxy terminal two thirds is comprised of an adenosine triphosphatase (ATPase)/helicase domain. These domains are essential for the maturation of the carboxy-terminal portion of the HCV polyprotein and catalyze the cap synthesis of the RNA genome. In this report, human and murine antibody responses induced by NS3 were characterized using a recombinant full-length NS3 (NS3-FL) protein, or the isolated protease or ATPase/ helicase domains, expressed and purified from Escherichia coli. Sera from 40 patients with chronic HCV infection were assayed in enzyme-linked immunoassays (EIAs) for antibody binding to the panel of NS3 proteins. Virtually all patient sera contained antibodies specific for NS3-FL and the ATPase/helicase domain, whereas only 10% of sera reacted with the protease domain of NS3. Human antibodies reactive with NS3-FL were highly restricted to the immunoglobulin G1 (IgG1) isotype and were inhibited by soluble ATPase/helicase, but not by the protease domain. The anti-NS3 (ATPase/helicase) reactivity decreased on denaturation by sodium dodecyl sulfate (SDS) and beta-mercaptoethanol (2ME), suggesting the recognition of nonlinear or conformational B-cell determinants. Similar to infected humans, mice immunized with NS3-FL developed high-titered primary antibody responses to the NS3 ATPase/ helicase domain, whereas an anti-NS3 protease response was not observed after primary or secondary immunizations. Thus, the human and murine humoral immune responses to the HCV NS3 protein are focused on the ATPase/helicase domain, are restricted to the IgG1 isotype in humans, and are conformationally dependent. Unexpectedly, in both species, the NS3 protease domain, present in the context of the full-length NS3, appears to possess low intrinsic immunogenicity in terms of antibody production.
Collapse
|
197
|
Albertine KH, Steiner RM, Radack DM, Golding DM, Peterson D, Cohn HE, Farber JL. Analysis of cell type and radiographic presentation as predictors of the clinical course of patients with bronchioalveolar cell carcinoma. Chest 1998; 113:997-1006. [PMID: 9554638 DOI: 10.1378/chest.113.4.997] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
Abstract
STUDY OBJECTIVES Bronchioloalveolar carcinoma is a primary lung neoplasm of variable histopathologic, radiologic, and clinical expression. There are three cell types described in bronchioloalveolar carcinoma: Clara cells, mucin-producing cells, and alveolar type II epithelial cells. It is unclear whether these three tumor cell types are associated with a specific radiologic presentation and clinical course. In this study, we investigated whether tumor cell type, identified by transmission electron microscopy, correlated with a specific radiologic pattern, and whether tumor cell type or radiologic presentation correlated with the patient's clinical course and outcome. DESIGN Transmission electron microscopy was used to restudy tissue blocks from the original surgical histopathologic specimens in 54 patients with primary bronchioloalveolar carcinoma diagnosed over a 10-year period (1980 to 1990). The pretreatment radiographs were reviewed in each case, and the first chest radiograph obtained at the time of the discovery of the tumor in each patient was compared with the results of the ultrastructural study. The medical records of each patient were examined to obtain pertinent radiologic, clinical, and patient outcome information. MEASUREMENT AND RESULTS There were 32 Clara cell tumors, 10 mucin-producing cell tumors, and 1 alveolar type II epithelial cell tumor in this series. Eleven additional tumors had mixtures of two or more cell types. No statistically significant relationship was detected between tumor cell type and radiologic presentation or patient mortality pattern. There was increased mortality among patients who presented radiologically with segmental, lobar, multifocal, or diffuse disease compared with those patients exhibiting a solitary pulmonary nodule at presentation. CONCLUSION Radiologic presentation, rather than tumor cell type, provides prognostic information that aids in predicting patient outcome.
Collapse
|
198
|
Stelmachowicz PG, Dalzell S, Peterson D, Kopun J, Lewis DL, Hoover BE. A comparison of threshold-based fitting strategies for nonlinear hearing aids. Ear Hear 1998; 19:131-8. [PMID: 9562535 DOI: 10.1097/00003446-199804000-00005] [Citation(s) in RCA: 22] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
OBJECTIVE In recent years, wide dynamic range compression (WDRC) has been used with increasing success. To optimize the fit with this type of hearing aid circuitry, subjective measures of loudness growth often are used. Unfortunately, these type of measures cannot be performed with infants, young children, and some elderly individuals. The primary purpose of this study was to compare the fitting recommendations of two recently described threshold-based procedures for fitting nonlinear hearing aids (DSL 4.0 and FIG6) to the use gain settings of satisfied adult hearing aid users for whom the fitting was based on subjective measures of loudness growth. Because it cannot be assumed that the use settings for adults will be appropriate for young children, a secondary goal was to quantify the audibility of speech at the use settings derived from loudness growth measures. DESIGN Forty-nine adult hearing aid users with mild to severe sensorineural hearing loss participated in this study. For all subjects, loudness growth measures were used to optimize the fit of a 2-channel WDRC hearing aid. The use gain at 50 and 80 dB SPL was compared with the gain recommended by DSL, FIG6, and the manufacturer's threshold-based fitting algorithm. RESULTS In general, both DSL and FIG6 prescribed more gain than actually was used by these hearing aid wearers. These discrepancies increased as a function of frequency, and differences in excess of 20 dB were observed in some cases. The manufacturer's algorithm provided a closer approximation to the use gain than either DSL or FIG6. Utilizing these use gain values, an Aided Audibility Index (AAI) was calculated for soft, average, and loud speech across four degrees of hearing loss, ranging from mild to severe (12 conditions). Transfer functions for continuous discourse and nonsense syllables were applied to yield estimated intelligibility scores. For the higher context speech materials, estimated intelligibility was > or = 85% for nine of the 12 conditions. For low-context speech materials, estimated intelligibility was > or = 85% for only three of the 12 conditions. CONCLUSIONS Results suggest that the gain recommendations provided by both DSL and FIG6 exceeded the gain actually used by the adult hearing-impaired subjects in this study. Gain recommendations from the manufacturer's algorithm provided a closer approximation to the use gain values of these subjects. These findings suggest that, for adult hearing aid users who cannot perform loudness judgments reliably, the manufacturer's algorithm would be expected to provide a closer approximation to loudness-based use gain values than either DSL or FIG6. However, AAI calculations revealed that the gain recommendations from this algorithm produce adequate audibility of speech only if one assumes linguistic competence. When AAI values are transformed to predict the intelligibility of low-context speech materials, it appears that the degree of audibility may not be appropriate for prelingually hearing-impaired children with more than a moderate hearing loss.
Collapse
|
199
|
Lazowick D, Meyer TJ, Pressman M, Peterson D. Orbital herniation associated with noninvasive positive pressure ventilation. Chest 1998; 113:841-3. [PMID: 9515870 DOI: 10.1378/chest.113.3.841] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
Abstract
A diagnosis of severe obstructive sleep apnea was made after a 52-year-old hypertensive man developed a large intracranial hemorrhage. Therapeutic noninvasive positive pressure ventilation (NPPV) for obstructive sleep apnea and hypoventilation was complicated by transient unilateral orbital herniation. As best as can be determined, this represents a new, potentially deleterious side effect of NPPV.
Collapse
|
200
|
Brusick D, Albertini R, McRee D, Peterson D, Williams G, Hanawalt P, Preston J. Genotoxicity of radiofrequency radiation. DNA/Genetox Expert Panel. ENVIRONMENTAL AND MOLECULAR MUTAGENESIS 1998; 32:1-16. [PMID: 9707093 DOI: 10.1002/(sici)1098-2280(1998)32:1<1::aid-em1>3.0.co;2-q] [Citation(s) in RCA: 74] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
During the past several years, concerns have been raised regarding the potential adverse effects of exposures to nonionizing radiation, particularly in the extremely low frequency (ELF) range (50 to 60 MHz) and radiofrequency radiation (RFR) with frequencies ranging from 30 KHz to 30,000 MHz. One focus of concern has been potential DNA interactions. Publications reviewing the genotoxicity of ELF radiation [McCann et al. (1993): Mutat Res 297(1):61-95; Murphy et al. (1993): Mutat Res 296:221-240; NAS (1997)], have been uniform in concluding that the weight of evidence does not indicate any genotoxic risk from exposure to this type of radiation. Concern that RFR may be associated with adverse biological effects [WHO, 1993], including recent allegations that they may be involved in the production of brain tumors in humans [Elmer-Dewit (1993): Time, February 8:42], has resulted in the production of a large number of publications describing the effects of RFR on the integrity of nucleic acids. Data from studies conducted in a frequency range from 800 to 3,000 MHz were reviewed and subjected to a weight-of-evidence evaluation. The evaluation focused on direct toxicological effects of RFR as well as on studies addressing basic biological responses to RFR at the cellular and molecular level. The data from over 100 studies suggest that RFR is not directly mutagenic and that adverse effects from exposure of organisms to high frequencies and high power intensities of RFR are predominantly the result of hyperthermia; however, there may be some subtle indirect effects on the replication and/or transcription of genes under relatively restricted exposure conditions.
Collapse
|